Trial Profile
Pilot Assessment of Lopinavir/Ritonavir and Maraviroc in Experienced Patients.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 24 Jun 2015
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Maraviroc
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms PALM
- 22 Jun 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 24 Feb 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 24 Feb 2010 Planned end date changed from 1 Mar 2011 to 1 Jul 2011 as reported by ClinicalTrials.gov.